CNP production in the kidney and effects of protein intake restriction in nephrotic syndrome

American Journal of Physiology - Renal Physiology

Volumn 283, Issue 3 52-3, 2002, Pages

  Cataliotti, Alessandro ^a   Giordano, Mauro ^b   De Pascale, Emanuela ^b   Giordano, Gelsomina ^b   Castellino, Pietro ^c   Jougasaki, Michihisa ^a   Costello, Lisa C ^a   Boerrigter, Guido ^a   Tsuruda, Toshihiro ^a   Belluardo, Paola ^c   Lee, Shang Chiun ^a   Huntley, Brenda ^a   Sandberg, Sharon ^a   Malatino, Lorenzo S ^c   Burnett, John C ^a  

^a MAYO CLINIC   (United States)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Immunohistochemistry; In situ hybridization; Low protein diet; Urinary C type natriuretic peptide

Indexed keywords

NATRIURETIC PEPTIDE TYPE C;

ADULT; ARTICLE; BINDING SITE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY BIOPSY; KIDNEY COLLECTING TUBULE; KIDNEY TUBULE; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN LOCALIZATION; PROTEIN RESTRICTION; PROTEIN TRANSPORT;

EID: 17344377159     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00372.2001     Document Type: Article

References (53)

1. Low-dose C-type natriuretic peptide does not affect cardiac and renal function in humans
2. Larginine-induced vasodilation in healthy humans: Phramacokinetic-pharmacodynamic relationship
3. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: Functional cardiorenal responses to receptor antagonism
4. Identification of "B" receptor for natriuretic peptide in human kidney
5. C-type natriuretic peptide inhibits mesangial cell proliferation, and matrix accumulation in vivo
6. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: Role for BNP as biomarker for ventricular remodeling
7. Biological actions, and pharmacokinetics of C-type natriuretic peptide in conscious sheep
8. C-type natriuretic peptide: The endothelial component of the natriuretic peptide system
9. Shear stress augments expression of C-type natriuretic peptide, and adrenomedullin
10. C-type natriuretic peptide: A selective cardiovascular peptide
11. Synthesis, and localization of C-type natriuretic peptide in mammalian kidney
12. Atrial natriuretic peptide, and chronic renal effects of changes in dietary protein and sodium intake in man
13. Neutral endopeptidase 24.11. (enkephalinase) and related regulators of peptide hormones
14. C-type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells
15. Novel natriuretic peptide, CNP, potently stimulates cyclic GMP production in rat cultured vascular smooth muscle cells
16. Effects of dietary protein restriction on fibrinogen, and albumin metabolism in nephrotic patients
17. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients
18. Detection of messenger RNA in routinely processed tissue sections with biotinylated oligonucleotide probes
19. Human renal response to a meat meal
20. C-type natriuretic peptide in chronic renal failure, and its action in humans
21. Effect of dietary protein intake on albumin homeostasis in nephrotic patients
22. C-type natriuretic peptide (CNP) in rats, and humans
23. Gene expression, and synthesis of natriuretic peptides by cultured human glomerular
24. Natriuretic peptides
25. Evaluation of the Coomassie brilliant blue G-250 method for urinary protein
26. Physiological role of silent receptors of atrial natriuretic factor
27. Protein restriction in the pre-end-stage renal disease (ESRD) patient: Who, when, how, and the effect on subsequent ESRD outcome
28. A method for estimation nitrogen intake of patients with chronic renal failure
29. Presence of C-type natriuretic peptide in human kidney, and urine
30. Atrial natriuretic peptide in the renal response to an acute protein load
31. Acute loading with proteins from different sources in healthy volunteers, and diabetic patients
32. CNP is present in canine renal tubular cells, and secreted by cultured opossum kidney cells
33. The nephrotic syndrome
34. Renal and vascular effects of C-type and atrial natriuretic peptides in humans
35. C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells
36. Roles of the mesangium in glomerular function
37. C-type natriuretic peptide inhibits rat mesangial cell proliferation by a phosphorylation-dependent mechanism. Naunyn Schmiedebergs
38. Increased C-type natriuretic peptide mRNA expression in the kidney of diabetic rats
39. Interactions between glomerular mesangial cells, cytokines, and extracellular matrix
40. Cardiovascular, and renal actions of C-type natriuretic peptide
41. Presence of C-type natriuretic peptide in cultured human endothelial cells, and plasma
42. C-type natriuretic peptide (C.N.P.): A new member of natriuretic peptide family identified in porcine brain
43. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide
44. Characterization of natriuretic peptide receptors in cultured cells
45. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: Possible existence of vascular natriuretic peptide system
46. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells
47. Evidence for C-type natriuretic peptide production in the rat kidney
48. Role of atrial natriuretic peptide in the increase in glomerular filtration rate induced by a protein meal
49. Gene and precursor structures of human C-type natriuretic peptide
50. Natriuretic peptides in the human kidney
51. Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome
52. Factor XIII its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmina, in plasma and urine of patients with nephrosis
53. Thrombus formation, and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions